Patient explainer · Learn
Mitochondrial Dysfunction
The Role of Mitochondrial Dysfunction in Disease Pathogenesis
This is a detailed subject, and what it means for your situation depends on your history and your imaging. Dr. Glowney is glad to work through it with you.
What mitochondrial dysfunction is.
Mitochondrial dysfunction is a critical pathological state characterized by the failure of mitochondria, the cellular organelles responsible for energy production and metabolic regulation, to perform their essential functions adequately. Mitochondria make energy and also help control cell death (apoptosis) and calcium balance, so their failure can disrupt all of these (Nunnari & Suomalainen, 2012; Tábara et al., 2025).
Mitochondria are important for generating ATP through oxidative phosphorylation, and their dysfunction is implicated in numerous diseases, including neurodegenerative disorders, metabolic syndromes, cardiovascular diseases, and aging (Srivastava, 2017).
Causes of mitochondrial dysfunction.
At the biomolecular level, mitochondrial dysfunction often involves impaired oxidative phosphorylation. In inherited mitochondrial diseases, this comes from mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that encode mitochondrial proteins (Gorman et al., 2016). The electron transport chain, comprising complexes I through IV and ATP synthase, is critical for maintaining the mitochondrial membrane potential and driving ATP synthesis. When mutations disrupt these complexes, electron leakage occurs, leading to excess reactive oxygen species production. Reactive oxygen species made by mitochondria cause oxidative damage in many diseases (Murphy, 2009). Disrupted electron flow also lowers ATP production, leaving energy-hungry tissues such as the brain short of energy (Federico et al., 2012).
Mitochondrial dysfunction can also arise from defective mitophagy, the cellular process responsible for removing damaged mitochondria. Inefficient mitophagy leads to the accumulation of dysfunctional mitochondria, which can increase oxidative stress and inflammation (Kong et al., 2025). Imbalanced fission and fusion, controlled by proteins such as DRP1 and OPA1, also contributes to dysfunction and disease (Yapa et al., 2021). These disruptions in mitochondrial turnover and dynamics play an important role in the pathogenesis of various diseases.
Ketones as a backup fuel.
When glucose is scarce, as in fasting, the liver turns fatty acids into ketone bodies that other tissues use for fuel, a process called ketogenesis (Kolb et al., 2021). Therapeutic strategies that target mitochondrial function, such as the ketogenic diet, have shown promise in managing certain neurological and metabolic disorders. (Vidali et al., 2015)
Wider cellular roles and research needs.
Mitochondrial dysfunction is a central pathological mechanism underlying numerous diseases, and a deeper understanding of the regulatory network governing mitochondrial integrity and dynamics is important for developing effective interventions. As mitochondria are central to cellular energy production, their dysfunction has consequences for many physiological processes. Disruption of mitochondrial function is a hallmark of numerous age-related disorders, so maintaining mitochondrial health is important in the context of aging (Srivastava, 2017).
The implications of mitochondrial dysfunction extend beyond energy production, as these organelles play an important role in various other cellular processes. Continued research in this field may yield insights into disease pathogenesis and new therapeutic strategies.
Mitochondrial dysfunction has been increasingly recognized as an important factor in the development and progression of a wide range of diseases, including neurodegenerative disorders, metabolic syndromes, cardiovascular diseases, and cancer. (Vidali et al., 2015) (Srivastava, 2017)
Given mitochondria's central role in cellular metabolism and signaling, their dysfunction can affect tissue and organ function. Strategies targeting mitochondrial dysfunction, such as the ketogenic diet, have shown promise in managing certain neurological and metabolic disorders. (Vidali et al., 2015)
The details of mitochondrial function and the consequences of their dysfunction are an active area of research, with implications for understanding and treating various diseases.
Links to disease and aging.
Emerging evidence suggests that mitochondrial dysfunction is a common thread in the pathogenesis of many neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease (Federico et al., 2012; Gao et al., 2017). Abnormal mitochondrial dynamics, including altered fission and fusion processes, have been linked to the development and progression of these neurological conditions (Yapa et al., 2021; Gao et al., 2017).
Mitochondrial dysfunction is also implicated in the pathology of metabolic syndromes, such as obesity, type 2 diabetes, and cardiovascular diseases. Impairment of mitochondrial function can contribute to developing these conditions through various mechanisms, including impaired energy production, increased oxidative stress, and disrupted cellular signaling.
Aging is another context in which mitochondrial dysfunction plays a central role. The gradual decline in mitochondrial integrity and function over time is believed to be a major driver of the aging process and the increased susceptibility to age-related disorders.
The study of mitochondrial dysfunction is an active area of research, with implications for understanding and treating a range of diseases.
References
Sources cited.
- Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012). Mitochondria, oxidative stress and neurodegeneration. Journal of the Neurological Sciences, 322(1–2), 254–262. https://doi.org/10.1016/j.jns.2012.05.030
- Gao, J., Wang, L., Liu, J., Xie, F., Su, B., & Wang, X. (2017). Abnormalities of mitochondrial dynamics in neurodegenerative diseases. Antioxidants, 6(2), 25. https://doi.org/10.3390/antiox6020025
- Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016). Mitochondrial diseases. Nature Reviews Disease Primers, 2, 16080. https://doi.org/10.1038/nrdp.2016.80
- Kolb, H., Kempf, K., Röhling, M., Lenzen-Schulte, M., Schloot, N. C., & Martin, S. (2021). Ketone bodies: From enemy to friend and guardian angel. BMC Medicine, 19(1), 313. https://doi.org/10.1186/s12916-021-02185-0
- Kong, L., Li, S., Fu, Y., Cai, Q., Du, X., Liang, J., & Ma, T. (2025). Mitophagy in relation to chronic inflammation/ROS in aging. Molecular and Cellular Biochemistry, 480(2), 721–731. https://doi.org/10.1007/s11010-024-05042-9
- Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochemical Journal, 417(1), 1–13. https://doi.org/10.1042/BJ20081386
- Nunnari, J., & Suomalainen, A. (2012). Mitochondria: In sickness and in health. Cell, 148(6), 1145–1159. https://doi.org/10.1016/j.cell.2012.02.035
- Srivastava, S. (2017). The mitochondrial basis of aging and age-related disorders. Genes, 8(12), 398. https://doi.org/10.3390/genes8120398
- Tábara, L. C., Segawa, M., & Prudent, J. (2025). Molecular mechanisms of mitochondrial dynamics. Nature Reviews Molecular Cell Biology, 26(2), 123–146. https://doi.org/10.1038/s41580-024-00785-1
- Vidali, S., Aminzadeh, S., Lambert, B., Rutherford, T., Sperl, W., Kofler, B., & Feichtinger, R. G. (2015). Mitochondria: The ketogenic diet, a metabolism-based therapy. The International Journal of Biochemistry & Cell Biology, 63, 55–59. https://doi.org/10.1016/j.biocel.2015.01.022
- Yapa, N. M. B., Lisnyak, V., Reljic, B., & Ryan, M. T. (2021). Mitochondrial dynamics in health and disease. FEBS Letters, 595(8), 1184–1204. https://doi.org/10.1002/1873-3468.14077
Related patient explainers